353 related articles for article (PubMed ID: 25889896)
1. Rho regulation: DLC proteins in space and time.
Braun AC; Olayioye MA
Cell Signal; 2015 Aug; 27(8):1643-51. PubMed ID: 25889896
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for spatiotemporal regulation of Rho-GTPase signaling at synapses.
Duman JG; Mulherkar S; Tu YK; X Cheng J; Tolias KF
Neurosci Lett; 2015 Aug; 601():4-10. PubMed ID: 26003445
[TBL] [Abstract][Full Text] [Related]
3. Positive regulation of Rho GTPase activity by RhoGDIs as a result of their direct interaction with GAPs.
Ota T; Maeda M; Okamoto M; Tatsuka M
BMC Syst Biol; 2015 Jan; 9():3. PubMed ID: 25628036
[TBL] [Abstract][Full Text] [Related]
4. The STAR of the DLC family.
El-Sitt S; El-Sibai M
J Recept Signal Transduct Res; 2013; 33(1):10-3. PubMed ID: 23316797
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for Rho GTPase signaling specificity.
Karnoub AE; Symons M; Campbell SL; Der CJ
Breast Cancer Res Treat; 2004 Mar; 84(1):61-71. PubMed ID: 14999155
[TBL] [Abstract][Full Text] [Related]
6. Regulation of deleted in liver cancer 1 tumor suppressor by protein-protein interactions and phosphorylation.
Ko FC; Ping Yam JW
Int J Cancer; 2014 Jul; 135(2):264-9. PubMed ID: 24114040
[TBL] [Abstract][Full Text] [Related]
7. Spatial Rho regulation: Molecular mechanisms controlling the GAP protein DLC3.
Hendrick J; Olayioye MA
Small GTPases; 2019 Jan; 10(1):13-19. PubMed ID: 27849131
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of the Rho GTPase signaling.
Hakoshima T; Shimizu T; Maesaki R
J Biochem; 2003 Sep; 134(3):327-31. PubMed ID: 14561717
[TBL] [Abstract][Full Text] [Related]
9. DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-β1 signaling.
Zhang K; Na T; Ge F; Yuan BZ
Exp Cell Res; 2020 Jan; 386(2):111732. PubMed ID: 31770531
[TBL] [Abstract][Full Text] [Related]
10. GAP-independent functions of DLC1 in metastasis.
Barras D; Widmann C
Cancer Metastasis Rev; 2014 Mar; 33(1):87-100. PubMed ID: 24338004
[TBL] [Abstract][Full Text] [Related]
11. Rho GEFs and GAPs: emerging integrators of extracellular matrix signaling.
Kutys ML; Yamada KM
Small GTPases; 2015; 6(1):16-9. PubMed ID: 25862162
[TBL] [Abstract][Full Text] [Related]
12. The Rho-specific GAP protein DLC3 coordinates endocytic membrane trafficking.
Braun AC; Hendrick J; Eisler SA; Schmid S; Hausser A; Olayioye MA
J Cell Sci; 2015 Apr; 128(7):1386-99. PubMed ID: 25673874
[TBL] [Abstract][Full Text] [Related]
13. Guanine nucleotide exchange factors for RhoGTPases: good therapeutic targets for cancer therapy?
Lazer G; Katzav S
Cell Signal; 2011 Jun; 23(6):969-79. PubMed ID: 21044680
[TBL] [Abstract][Full Text] [Related]
14. Regulating Rac in the nervous system: molecular function and disease implication of Rac GEFs and GAPs.
Bai Y; Xiang X; Liang C; Shi L
Biomed Res Int; 2015; 2015():632450. PubMed ID: 25879033
[TBL] [Abstract][Full Text] [Related]
15. Rho GTPase expression in tumourigenesis: evidence for a significant link.
Gómez del Pulgar T; Benitah SA; Valerón PF; Espina C; Lacal JC
Bioessays; 2005 Jun; 27(6):602-13. PubMed ID: 15892119
[TBL] [Abstract][Full Text] [Related]
16. DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
Wang D; Qian X; Rajaram M; Durkin ME; Lowy DR
Oncotarget; 2016 Jul; 7(29):45144-45157. PubMed ID: 27174913
[TBL] [Abstract][Full Text] [Related]
17. Biochemical assays to characterize Rho GTPases.
Jaiswal M; Dubey BN; Koessmeier KT; Gremer L; Ahmadian MR
Methods Mol Biol; 2012; 827():37-58. PubMed ID: 22144266
[TBL] [Abstract][Full Text] [Related]
18. Molecular perturbation strategies to examine spatiotemporal features of Rho GEF and Rho GTPase activity in living cells.
Goedhart J; van Unen J
Small GTPases; 2019 May; 10(3):178-186. PubMed ID: 28521592
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Rho signaling pathways in interleukin-2-stimulated human T-lymphocytes.
Mzali R; Seguin L; Liot C; Auger A; Pacaud P; Loirand G; Thibault C; Pierre J; Bertoglio J
FASEB J; 2005 Nov; 19(13):1911-3. PubMed ID: 16148026
[TBL] [Abstract][Full Text] [Related]
20. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
